# Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome

> **NCT02967718** · — · UNKNOWN · sponsor: **Jingqing Hu** · enrollment: 13000 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02967718
- **Lead sponsor:** Jingqing Hu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2017-03
- **Final completion:** 2017-12
- **Target enrollment:** 13000 (ESTIMATED)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967718, "Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02967718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*